Bloomberg Markets & Finance via Youtube


Jun.17 — Pfizer Inc. will buy Array BioPharma Inc. for $10.6 billion to gain its promising new medicines for cancer, which could end or limit the use of punishing …

READ ALSO  Arthur J. Gallagher: Maintaining Its Sound Financials To Achieving Real Growth (NYSE:AJG)